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Abstract: Very old adults are at increased risk of folate and vitamin B12 deficiencies due to reduced
food intake and gastrointestinal absorption. The main aim was to determine the association between
folate and vitamin B12 intake from total diets and food groups, and status. Folate or vitamin B12
intakes (2 × 24 h multiple pass recalls) and red blood cell (RBC) folate or plasma vitamin B12
(chemiluminescence immunoassays) concentrations were available at baseline for 731 participants
aged 85 from the Newcastle 85+ Study (North-East England). Generalized additive and binary
logistic models estimated the associations between folate and vitamin B12 intakes from total diets
and food groups, and RBC folate and plasma B12. Folate intake from total diets and cereal and cereal
products was strongly associated with RBC folate (p < 0.001). Total vitamin B12 intake was weakly
associated with plasma vitamin B12 (p = 0.054) but those with higher intakes from total diets or
meat and meat products were less likely to have deficient status. Women homozygous for the FUT2
G allele had higher concentrations of plasma vitamin B12. Cereals and cereal products are a very
important source of folate in the very old. Higher intakes of folate and vitamin B12 lower the risk of
“inadequate” status.
Keywords: ‘aged 80 and over’; Newcastle 85+ Study; red blood cell folate; vitamin B12; FUT2;
MTHFR; food groups
1. Introduction
B vitamins, specifically folate and vitamin B12, are essential for one-carbon transfer reactions
which include amino acid interconversions, RNA and DNA synthesis and methylation of cell
macromolecules [1]. Older adults are at increased risk of B vitamin deficiencies due to decreased
food intake and increased malabsorption. Low folate and vitamin B12 status have been associated
with adverse health outcomes, including cognitive impairment [2–4], stroke [5,6], fractures [7,8] and
cancer in older adults [9]. A review of micronutrient deficiencies in community-dwelling older adults
(aged 65 and over) living in western countries reported that 29% and 16% of men and, 30% and
19% of women had intakes below the Nordic Nutrition Recommendations (NNR) estimated average
requirement (EAR) for folate (200 µg/day) and vitamin B12 (1.4 µg/day), respectively [10]. The current
UK National Diet and Nutrition Survey (NDNS) rolling programme estimated that 1% of older adults
(aged 65 and over) were below the UK lower reference nutrient intake (LRNI) for folate (100 µg/day)
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and vitamin B12 (1.0 µg/day) but that 7.3% of men and 10.8% of women had red blood cell folate (RBC)
concentrations below 340 nmol/L and 5.9% of men and women had serum vitamin B12 concentrations
below 150 pmol/L [11]. The complexity of the dose–response relationships between intake and
status is influenced by limitations in dietary assessment, food composition data, choice of biomarkers,
genotypic variation, bioavailability and complex metabolic pathways. About 10%–30% of older
adults have atrophic gastritis (caused by Helicobacter pylori infection, long-term use of proton pump
inhibitors, H2 receptor antagonists and biguanides) which leads to hypochlorhydria [12]. This has
a detrimental effect onacid–pepsin digestion and favours small bowel bacterial growth resulting in
impaired vitamin B12 absorption [13]. In addition, those with autoimmune atrophic gastritis produce
antibodies against the intrinsic factor which can lead to pernicious anemia [13]. Therefore, older adults
may have adequate vitamin B12 intake but inadequate vitamin B12 plasma concentration. In addition,
several single nucleotide polymorphisms (SNP) modulate folate and vitamin B12 status. For example,
homozygosity of the T allele (forward orientation) (rs1801133) of the MTHFR gene (which encodes
methylenetetrahydrofolate reductase) is associated with low folate status [14].
There is conflicting evidence about relationships between folate and vitamin B12 intake and, folate
and vitamin B12 status, respectively, in older adults. Some studies report a significant association
between folate and vitamin B12 intake and status in older adults [2,15–19] while others do not [20–22].
Differences in folate and vitamin B12 bioavailability from total diets and specific food sources may
provide a partial explanation for the observed discrepancies. Folate bioavailability from foods is
substantially lower than that from supplements or from foods fortified with folic acid with estimated
bioavailability of 50% and 85%, respectively [23]. If intrinsic factor (IF) secretion is intact, approximately
40% of vitamin B12 is absorbed [24].
In light of the concerns about dietary inadequacy, it is imperative to assess folate and vitamin
B12 status in older people, particularly the very old (85 years and older). The aims were to determine
(i) the prevalence of “inadequate” folate and vitamin B12 intake and status in the Newcastle 85+
Study; (ii) the associations between the top contributing dietary sources of folate and vitamin B12, and
status; and (iii) whether high dietary intakes of both vitamins are associated with a reduced risk of
“inadequate” status.
2. Material and Methods
2.1. Newcastle 85+ Study
The Newcastle 85+ Study is a longitudinal population-based study of health trajectories and
outcomes in the very old which approached all people turning 85 in 2006 (born in 1921) who
were registered with participating general practices within Newcastle upon Tyne or North Tyneside
primary care trusts (North East England). Details of the study have been reported elsewhere [25–27].
All procedures involving human subjects were approved by the Newcastle and North Tyneside local
research ethics committee (06/Q0905/2). Written informed consent was obtained from all participants,
and when unable to do so, consent was obtained from a carer or a relative. The recruited cohort was
socio-demographically representative of the general UK population [25]. At baseline (2006/2007),
multidimensional health assessment, complete general practice (GP) medical records data and complete
dietary intake data (without protocol violation) were available for 793 participants [28].
2.2. Dietary Assessment and Food Groups
Dietary intake was collected at baseline using two 24 h Multiple Pass Recalls (24 h-MPR) on two
non-consecutive occasions in the participant’s usual residence by a trained research nurse and energy,
folate and vitamin B12 intakes were estimated using the McCance and Widdowson's Food Composition
tables 6th edition [29]. Individual foods were coded and allocated to 15 first level food groups that
consisted of: cereals and cereal products, milk and milk products, eggs and egg dishes, oils and fat
spreads, meat and meat products, fish and fish dishes, vegetables, potatoes, savoury snacks, nuts
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and seeds, fruit, sugar, preserves and confectionery, non-alcoholic beverages, alcoholic beverages and
miscellaneous (soups, sauces and remaining foods that did not belong in other food groups) [28]. The
top three food group contributors to folate or vitamin B12 intakes (accounted for >50% of total intake)
were included in the analysis. These food groups were also widely consumed by this population and,
therefore, a possible target for public health policies/fortification. Information on supplement use was
limited to type and brand and, therefore, this was only used as a dichotomous covariate (yes/no) [30].
2.3. Nutritional Biomarkers and Single Nucleotide Polymorphisms
Blood samples were taken after an overnight fast at baseline. Forty mL of blood was drawn from
the antecubital vein between 7:00 a.m. and 10:30 a.m., placed on ethylenediamine tetraacetic acid
(EDTA) tubes and 95% of the samples were taken to the laboratory within 1 h [31]. Red blood cell
folate (RBC folate) and plasma vitamin B12 concentrations were determined by chemiluminescence
(Microparticle Immunoassay on an Abbott ARCHITECT analyser) and data were available for 731 and
732 participants, respectively. RBC folate was stabilized with ascorbic acid and adjusted for hematocrit.
Whole blood DNA was extracted by means of a QiaGEN Amp Maxi DNA Purification Kit. As part of
the EU Longevity Genetics Consortium, genome-wide association studies (GWAS) were performed on
765 participants from the Newcastle 85+ Study using Illumina Omni genotyping arrays. Data were
obtained from 710 individuals and after quality control, 642 individuals were retained for the final
analysis [32]. The single nucleotide polymorphisms (SNP) in the MTHFR (rs1801133, chromosome 1,
position 11796321), FUT2 (rs492602, chromosome 19, position 48703160), MTR (rs1805087, chromosome
1, position 236885200) and TCN1 (rs526934, chromosome 11, position 59866020) genes were chosen as
candidate modifiers of RBC folate and plasma vitamin B12 concentrations. All SNPs were assessed for
deviation from the Hardy–Weinberg equilibrium.
2.4. Statistical Analysis
Normality was assessed graphically with the aid of Q-Q plots and histograms. Linearity and
homoscedasticity assumptions were tested with residuals versus predicted values plots. Normally
distributed continuous values are presented as means and standard deviations (SD), and non-Gaussian
distributed variables as medians and interquartile ranges (IQR). Categorical data are presented as
percentages (with corresponding sample size). Sex differences were assessed with the Chi-squared test
(χ2) for categorical variables and by independent t-test, and Mann–Whitney U test for parametric and
non-parametric continuous data, respectively. Differences between RBC folate and plasma vitamin
B12 concentrations according to MTHFR (rs1801133), MTR (rs1805087), TCN1 (rs526934) and FUT2
(rs492602) genotype were assessed using Kruskal–Wallis tests followed by Dunn–Bonferoni tests if the
null hypothesis was rejected.
The semi-parametric generalized additive models (gam) were investigated in R version 3.0.1
(R foundation for statistical computing) using the package “gam” to plot the relationship between
vitamin intakes (thin plate regression splines for smoothing) and corresponding biomarkers.
The generated reference value of zero in the y-axis corresponds to the RBC folate/ plasma vitamin B12
concentrations for the mean intake of folate and vitamin B12, respectively. The odds ratio (OR) (and
95% confidence intervals (CI)) of RBC folate concentrations <600 nmol/L and plasma B12 <148 pmol/L
according to quartiles of folate and vitamin B12 intake from total diets and top contributing food
groups were computed using binary logistic regression. The commonly used cut-off to define folate
deficiency of RBC folate <340 nmol/L [23] could not be used for these models due to the low percentage
of deficiency among study participants. Gam and binary logistic regression models were adjusted for
sex, energy intake, folic acid or vitamin B12 containing supplement use, folate/vitamin B12 intake from
other food groups, MTHFR or FUT2 genotype. The vitamin B12 models were additionally adjusted for
H2 receptor antagonists, biguanides and proton pump inhibitor (PPI) use.
p < 0.05 was considered statistically significant. Apart from the gam models, all statistical analyses
were conducted using the IBM statistical tool SPSS v22 (IBM, New York, NY, USA).
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3. Results
3.1. Folate and Vitamin B12 Intake and Status “Inadequacies”
Although 43% of participants (n = 335) consumed one or more supplements on a regular basis [30],
only 4.8% were users of folic acid and vitamin B12 as part of multivitamin supplements (Table 1).
A low percentage of participants (3.1%) had folate intakes below the UK LRNI (100 µg/day) [33]
or had RBC folate concentrations below the classic cut-off for deficiency of 340 nmol/L (3.6%) [23].
Folate intake and status were “inadequate” in only five participants. Cereals and cereal products,
vegetables and fruit and fruit juice were the top food group contributors to folate intake, explaining
almost 60% of total folate intake. Vitamin B12 intakes were below the UK LRNI (1 µg/day) [33] in
9.2% (n = 67) of the population while 17.1% (n = 125) were below 148 pmol/L of plasma vitamin
B12 [24] (110 of these 125 had also total homocysteine concentrations >15 µmol/L). In addition,
17 participants had “inadequate” intakes and also deficient plasma concentrations of vitamin B12.
There were twice as many women with vitamin B12 intakes below the UK LRNI than men (5.0% vs.
12.4%, p < 0.001) but not based on plasma vitamin B12 concentrations <148 pmol/L (17.4% vs. 16.9%,
p = 0.238). Eighty-six percent (n = 628) of the participants had plasma vitamin B12 concentration
<400 pmol/L, a concentration that has been associated with high total homocysteine and methylmalonic
acid concentrations [34,35]. Intake of the top three food groups (meat, fish and dairy) explained more
than 80% of total vitamin B12 intake.
Table 1. Population characteristics, folate and vitamin B12 intakes and biomarkers of one carbon
metabolism in the Newcastle 85+ Study.
All Men Women p-Value 1
Sex (%) (n) 732 39 (287) 61 (445) -
BMI (kg/m2) (mean ± SD) 24.4 ± 4.3 24.7 ± 3.9 24.3 ± 4.6 0.244 2
Smokers (%) (n) 5.6 (41) 4.2 (12) 6.5 (29) 0.183
Alcohol Drinkers (%) (n) 72 (364) 84 (192) 62 (172) <0.001
Total Energy Intakes
(MJ/day) 6.78 (5.62–8.31) 8.01 (6.65–9.59) 6.26 (5.17–7.38) <0.001
Folate and vitamin B12
supplement use (%) (n) 4.8 (35) 3.8 (11) 5.4 (24) 0.334
H2 antagonists, PPI and
biguanides use (%) (n) 26.8 (196) 27.2 (78) 26.5 (118) 0.844
Total Homocysteine
(µmol/L) 16.7 (13.5–21.4) 18.0 (14.5–21.9) 16.1 (13.1–21.0) 0.001
>15 µmol/L (%) (n) 63.1 (471) 70.3 (206) 58.5 (265) 0.001
Folate
Intake (µg/day) 209 (157–265) 246 (185–296) 189 (144–242) <0.001
<100 µg/day (%) (n) 3.1 (23) 0.7 (2) 4.7 (21) 0.002
Top food group contributors Cereals (32%), Vegetables(16%), Fruit (9%)
Cereals (32%), Vegetables
(15%), Fruit (8%)
Cereals (31%), Vegetables
(17%), Fruit (10%) -
Red Blood Cell Folate
(nmol/L) 863 (451–1287) 868 (596–1282) 854 (614–1287) 0.728
<340 nmol/L (%) (n) 3.6 (26) 2.1 (6) 4.5 (20) 0.103
Vitamin B12
Intake (µg/day) 2.9 (1.9–4.4) 3.5 (2.2–5.2) 2.5 (1.6–3.9) <0.001
<1.0 µg/day (%) (n) 9.2 (67) 4.5 (13) 12.1 (54) <0.001
Top food group contributors Meat (53%), Fish (17%),Milk (13%)
Meat (59%), Fish (16%),
Milk (10%)
Meat (48%), Fish (19%),
Milk (15%) -
Plasma Vitamin B12
(pmol/L) 232 (170–324) 228 (166–309) 238 (174–337) 0.238
<148 pmol/L (%) (n) 17.1 (125) 17.4 (50) 16.9 (75) 0.841
BMI, body mass index; Cereals, Cereals and cereal products; Fruit, Fruit and fruit juice; Meat, Meat and meat
products; Fish, Fish and fish dishes; Milk, Milk and milk products; PPI, proton pump inhibitors. Values are
medians and IQR unless otherwise stated. 1 No sex difference by Chi-squared test (χ2) for categorical or
Mann–Whitney test for non-parametric continuous variables; 2 Independent t-test.
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3.2. Folate, Vitamin B12 Status and Genotype
RBC folate and plasma vitamin B12 concentrations according to FUT2, MTHFR, MTR and TCN1
and genotypes are shown in Table 2. Individuals with the MTHFR (rs1801133) AG or GA genotype
[minor allele frequency (MAF) = 0.33 in the Newcastle 85+ Study vs. 0.32 for the A allele from
the 1000 Genomes Project British population phase 3 [36]] had higher RBC folate concentrations
than those homozygous for G (p = 0.024). Participants with the FUT2 (rs492602) GG genotype had
higher concentrations of plasma vitamin B12 than other FUT2 genotypes (p < 0.001) (MAF = 0.45 in the
Newcastle 85+ Study vs. 0.48 for the G allele in residents of England and Scotland [36]). The association
between FUT2 genotype and plasma vitamin B12 concentrations was significant in women (p < 0.001)
but not in men (p = 0.140).
Table 2. Plasma vitamin B12 and RBC folate concentrations by FUT2, MTHFR, MTR, and TCN1
genotypes in the Newcastle 85+ Study.
RBC Folate (nmol/L) p-Value 1 Plasma Vitamin B12 (pmol/L) p-Value 1
FUT2 (rs492602) 0.531 <0.001
AA (n = 128) 894 (629–1349 216 (146–281) Ref.
A/G (n = 308) 917 (603–1322) 221 (163–309) 0.413
GG (n = 187) 835 (595–1206) 277 (209–381) <0.001
MTHFR (rs1801133) 0.028 0.244
GG (n = 276) 871 (614–1275) Ref. 234 (168–331)
A/G (n = 279) 845 (584–1263) 1.000 230 (164–312)
AA (n = 67) 1010 (693–1626) 0.060 249 (193–339)
MTR (rs1805087) 0.547 0.277
AA (n = 419) 881 (613–1278) 240 (173–337)
A/G (n = 178) 845 (596–1332) 226 (162–297)
GG (n = 26) 1053 (580–1593) 247 (162–310)
TCN1 (rs526934) 0.065 0.298
AA (n = 331) 877 (606–1317) 237 (178–336)
A/G (n = 247) 845 (595–1223) 231 (160–325)
GG (n = 45) 1074 (630–1439) 222 (182–273)
RBC folate, Red blood cell folate; FUT2, Fucosyltrasnferase 2; MTHFR, Methylenetetrahydrofolate reductase;
MTR, Methionine synthase; TCN1, Transcobalamin 1. Ref., Reference used for post hoc comparisons.
1 Kruskal–Wallis test followed by Dunn–Bonferroni post-hoc test if the null hypothesis was rejected.
3.3. Association between Folate Intake and Status
The associations between folate intake from all food sources, from cereals and cereal products,
from fruit and fruit juice and from vegetables, and RBC folate concentrations are shown in Figure 1
(gam model adjusted for sex, energy intake, MTHFR genotype, folate intake from the two other food
groups and folic acid supplement use). Total folate intakes were associated with RBC folate (p < 0.001).
The steepest part of the dose–response curve appeared to be for folate intakes of 50–200 µg per day but
RBC folate concentrations continued to increase with increasing folate intake up to ≈500 µg per day.
Folate intake from cereals and cereal products, and from fruit and fruit juice were also associated with
RBC folate concentrations (p < 0.001 and p = 0.014, respectively) (Figure 1).
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cereals and cereal products, C. from fruit and fruit juice and D. from vegetables. Generalized additive model (gam) adjusted for sex, energy intake, MTHFR 
genotype, folic acid supplement use and folate intake from the two other food sources. The highest 2.5th percentiles of RBC folate concentrations are not 
included. Three participants with a folate intake above 150 μg only from vegetables were not included. One participant with a folate intake of 327 μg only 
from fruit and fruit juice was excluded. p values are from the corresponding gam model. 
Figure 1. Estimated difference from the mean (and 95% CI) of RBC folate concentration according to folate intake from A. all dietary sources, B. from cereals and
cereal products, C. from fruit and fruit juice and D. from vegetables. Generalized additive model (gam) adjusted for sex, energy intake, MTHFR genotype, folic acid
supplement use and folate intake from the two other food sources. The highest 2.5th percentiles of RBC folate concentrations are not included. Three participants with
a folate intake above 150 µg only from vegetables were not included. One participant with a folate intake of 327 µg only from fruit and fruit juice was excluded.
p values are from the corresponding gam model.
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3.4. Risk of Low Folate Status by Folate Intake
Table 3 shows the odds ratio (OR) (and 95% CI) of low RBC folate (<600 nmol/L) according
to total, cereals and cereal products, vegetables and, fruit and fruit juice folate intake quartiles.
Individuals in the highest quartile of total folate intake (>264 µg/day) were less likely to have RBC
folate concentrations <600 nmol/L than those in the lowest quartile (<157 µg/day) in the unadjusted
model (OR: 0.58, 95% CI: 0.36, 0.94) and adjusted model (OR: 0.43, 95% CI: 0.23, 0.82). Individuals in
higher quartiles of folate intake from cereals and cereal products and from vegetables were also less
likely to have low RBC folate concentrations (<600 nmol/L) than those in quartile 1. The same was not
true for folate intake from fruit and fruit juice in any model.
Table 3. Odds ratio (95% CI) of low RBC folate concentration according to quartiles of total folate
intake and intakes from cereals and cereal products, from vegetables and from fruit and fruit juice in
the Newcastle 85+ Study.
Folate Intake Model 1 (Unadjusted) Model 2 (Adjusted)
Total (µg/day) <600 nmol/L (n = 170) p <600 nmol/L (n = 170) p
<157 1.00 (ref.) - 1.00 (ref.) -
157–208 0.64 (0.40, 1.04) 0.071 0.65 (0.38, 1.09) 0.103
209–264 0.72 (0.45, 1.15) 0.173 0.58 (0.34, 1.02) 0.057
>264 0.58 (0.36, 0.94) 0.028 0.43 (0.23, 0.82) 0.010
Cereals and Cereal products (µg/day) <600 nmol/L (n = 170) p <600 nmol/L (n = 170) p
<36 1.00 (ref.) - 1.00 (ref.) -
36–59 0.96 (0.61, 1.49) 0.840 0.84 (0.51, 1.38) 0.493
59–92 0.40 (0.24, 0.66) <0.001 0.32 (0.18, 0.57) <0.001
>92 0.41 (0.25, 0.68) 0.001 0.33 (0.18, 0.61) <0.001
Vegetables (µg/day) <600 nmol/L (n = 154) p <600 nmol/L (n = 154) p
<15 1.00 (ref.) - 1.00 (ref.) -
15–30 0.72 (0.43, 1.21) 0.212 0.49 (0.25, 0.95) 0.035
30–51 0.86 (0.52, 1.41) 0.550 0.59 (0.32, 1.08) 0.089
>51 0.79 (0.48, 1.30) 0.357 0.52 (0.28, 0.99) 0.045
Fruit and Fruit Juice (µg/day) <600 nmol/L (n = 127) p <600 nmol/L (n = 127) p
<7.3 1.00 (ref.) - 1.00 (ref.) -
7.3–16 0.90 (0.53, 1.52) 0.682 1.01 (0.56, 1.83) 0.979
16–34 0.61 (0.35, 1.07) 0.086 0.67 (0.36, 1.25) 0.213
>34 0.76 (0.44, 1.31) 0.329 0.79 (0.43, 1.44) 0.437
RBC folate, Red blood cell folate; p, p-value. Low folate status was defined as RBC folate concentration
<600 nmol/L. Binary logistic regression model. Model 1 is unadjusted and Model 2 is adjusted for sex, energy
intake, folate intake from the other two food sources (except for total folate), MTHFR genotype and folic
acid-containing supplement use.
3.5. Association between Vitamin B12 Intake and Status
Total vitamin B12 intake was weakly associated with plasma vitamin B12 concentrations while
adjusting for sex, energy intake, vitamin B12 intake from the other two food groups, FUT2 genotype,
vitamin B12 supplement use and H2 antagonists, biguanides or PPI use (p = 0.054) (Figure 2).
Plasma vitamin B12 concentration appeared to decrease when vitamin B12 intake exceeded 10 µg/day
but the CI were very wide thereafter. Vitamin B12 intake from meat and meat products, milk and milk
products and fish and fish dishes were not associated with plasma vitamin B12 concentration.
Nutrients 2016, 8, 604 8 of 15
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Figure 2. Estimated difference from the mean (and 95% CI) of plasma B12 concentrations according to vitamin B12 intake from A. all dietary sources, B. from meat and
meat products, C. from milk and milk products and D. from fish and fish products. Generalized additive model (gam) adjusted for sex, energy intake, FUT2 genotype,
H2 antagonists, proton pump inhibitors or biguanides use, vitamin B12 supplement use and vitamin B12 intakes from the other two food sources. The lowest and
highest 2.5th percentiles of vitamin B12 intakes and plasma vitamin B12 concentrations are not included except for meat and meat products where the highest 5th
percentile was excluded. p values are from the corresponding gam model.
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3.6. Risk of Deficient Vitamin B12 Status by Vitamin B12 Intake
Participants with total vitamin B12 intake above the median (2.88 µg/day) were half as likely
to be deficient for plasma B12 as those with the lowest intake (<1.87 µg/day) in the adjusted model
(Table 4). Individuals in quartile 4 of vitamin B12 intake from meat and meat products (>2.10 µg/day)
were also half as likely to be deficient for plasma vitamin B12 as those in quartile 1 in the unadjusted
(OR: 0.55, 95% CI: 0.31–0.98) and adjusted models (OR: 0.41, 95% CI: 0.20–0.81). The same trend was
present for milk and milk products but this did not reach statistical significance (p = 0.054).
Table 4. Odds ratio (95% CI) of plasma vitamin B12 deficiency according to quartiles of intake of total
vitamin B12 and intakes from meat and meat products, from fish and fish products, and from milk and
milk products in the Newcastle 85+ Study.
Vitamin B12 Intake Model 1 (Unadjusted) Model 2 (Adjusted)
Total (µg/day) <148 pmol/L (n = 125) p <148 pmol/L (n = 125) p
<1.87 1.00 (ref.) - 1.00 (ref.) -
1.87–2.88 0.70 (0.42, 1.18) 0.180 0.57 (0.32, 1.01) 0.056
2.88–4.40 0.60 (0.35, 1.02) 0.057 0.50 (0.28, 0.92) 0.026
>4.40 0.53 (0.31, 0.92) 0.024 0.40 (0.21, 0.76) 0.005
Meat and Meat products (µg/day) <148 pmol/L (n = 118) p <148 pmol/L (n = 118) p
<0.35 1.00 (ref.) - 1.00 (ref.) -
0.35–1.03 0.72 (0.42, 1.24) 0.236 0.69 (0.38, 1.25) 0.220
1.03–2.10 0.84 (0.50, 1.44) 0.533 0.78 (0.43, 1.42) 0.422
>2.10 0.55 (0.31, 0.98) 0.043 0.41 (0.20, 0.81) 0.010
Fish and Fish products (µg/day) <148 pmol/L (n = 43) p <148 pmol/L (n = 43) p
<0.46 1.00 (ref.) - 1.00 (ref.) -
0.46–1.06 0.61 (0.23, 1.65) 0.331 0.66 (0.23, 1.91) 0.444
1.06–2.45 0.86 (0.34, 2.15) 0.743 0.66 (0.23, 1.86) 0.427
>2.45 1.00 (0.41, 2.42) 0.992 0.70 (0.25, 1.97) 0.503
Milk and Milk products (µg/day) <148 pmol/L (n = 102) p <148 pmol/L (n = 102) p
<0.27 1.00 (ref.) - 1.00 (ref.) -
0.27–0.53 0.84 (0.47, 1.52) 0.562 0.88 (0.46, 1.71) 0.711
0.53–0.88 1.12 (0.64, 1.96) 0.698 1.28 (0.70, 2.37) 0.425
>0.88 0.58 (0.31, 1.08) 0.086 0.49 (0.24, 1.01) 0.054
p, p-value. Binary logistic regression model. Deficient plasma vitamin B12 concentration was defined as
<148 pmol/L. Model 1 is unadjusted and Model 2 is adjusted for sex, energy intake, FUT2 genotype, vitamin B12
intake from the other two food sources (except total vitamin B12 intake), vitamin B12 containing supplement
use, H2 antagonists, biguanides and proton pump inhibitors use.
4. Discussion
This study found that, in the very old, folate intakes from all food sources and from cereals and
cereal products were significantly associated with RBC folate. Individuals with higher total folate
intake or intake from cereals and cereal products were less likely to have low concentrations of RBC
folate. The association between vitamin B12 intakes and plasma vitamin B12 was weak. Individuals
with vitamin B12 intakes from all food sources and from meat and meat products were also less likely
to be deficient for plasma vitamin B12. In addition, higher concentrations of RBC folate were found
in participants with the MTHFR (rs1801133) AA genotype compared with those with A/G or GG
genotypes. Women homozygous for the FUT2 (rs492602) G allele also had higher concentrations of
plasma vitamin B12 than those with other FUT2 genotypes.
4.1. Folate and Vitamin B12 Intake and Status “Inadequacies”
In the Newcastle 85+ Study there was a relatively low prevalence of “inadequate” folate
intake (3.1%) and status (3.6%). The NDNS rolling programme estimated that 1% of older adults
(aged 65 and over) were below the UK LRNI for folate but that 7.3% of men and 10.8% of women had
RBC folate concentrations <340 nmol/L. In the Newcastle 85+ Study, plasma vitamin B12 deficiency
(<148 pmol/L) was present in 17.1% of participants and 9.2% were below the UK LRNI (1 µg/day)
for vitamin B12 intake whilst the NDNS estimated that 1% were below the LRNI for vitamin B12 but
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5.9% had serum vitamin B12 concentrations <150 pmol/L [11]. Age, dietary assessment method (4-day
weighted diet record vs. 2 × 24 h-MPR) and other methodological differences are likely explanations
for these observed discrepancies. Specifically, the novel method used to assess RBC folate in the NDNS
(whole blood folate by a microbiological assay, serum total folate by LC-MS/MS and hematocrit) is
likely to give higher estimates of folate “inadequacy” than the one used in this study. The NDNS used
a similar method to the Newcastle 85+ Study to assess plasma vitamin B12 (competitive immunoassay
with direct chemiluminescence (ADVIA Centaur B12 assay)).
In the post-fortification period in the US, less than 1% of older adults had deficient folate status
(RBC folate <340 nmol/L) [37]. In the National Health and Nutrition Examination Survey (NHANES)
2003–2006, it was estimated that 9% of men and 24% of women >70 years old were below the North
American EAR for folate (320 DFE/day [38,39]). In the same NHANES edition, 19% of older adults
had plasma vitamin B12 concentrations below 221 pmol/L [40]. Moreover, less than 1% of men and
6% of women >70 years were below the EAR for vitamin B12 (2 µg/day) [39]. Almost 30% (n = 235) of
the Newcastle 85+ Study participants were below the same EAR for vitamin B12 intake.
4.2. Association between Folate Intake and Status
Folate intake from total diets and from cereals and cereal products but not from vegetables or
fruit and fruit juice were associated with RBC folate concentrations in the very old. Vegetables and
fruit and fruit juice contributed to 16% and 9%, respectively to folate intake and the relatively lower
contribution might explain the lack of associations. Further, folate bioavailability is dependent on the
food matrix, stability of labile folates, presence of vitamin C and folate-binding proteins and folate pool
sizes [23,41,42]. Nonetheless, there is a consensus that folic acid is better absorbed than dietary folate.
Evidence also shows that that folic acid intake is a stronger predictor of RBC folate concentration than
total folate intake [43]. The US Institute of Medicine estimated that the absorption efficiency of folic
acid in supplements or fortified food was 85% taken with food or 100% from supplements taken on
an empty stomach [23], whilst dietary folate absorption efficiency was 50% [23,42]. Breakfast cereals
(grouped under cereals and cereal products in this study) have frequently been the target of voluntary
fortification in the UK and elsewhere which might explain the stronger association between folate
intake from cereals and cereal products and RBC folate concentrations. Cereals and cereal products
were also the top contributors to folate intake (32%), suggesting that this is an important source of
folate/folic acid in this population group. On the other hand, the incomplete release of dietary folate
from plant foods cellular structures may explain a weaker association between folate from vegetables
and fruit, and RBC folate.
4.3. Association between Vitamin B12 Intake and Status
Total vitamin B12 was weakly associated with plasma B12 in the very old (p = 0.054) and seemed
to saturate at intakes ≈10 µg. The relatively weak association might be due to the low vitamin B12
intakes in relation to the large liver stores (1 µg/g of liver) so that intakes only slowly influence plasma
concentrations [24]. Further, vitamin B12 absorption is complex. Bound to protein in food, vitamin B12
has to be released by pepsin and hydrochloric acid in the stomach. The ensuing free form of vitamin
B12 binds to haptocorrin, forming a B12-haptocorrin complex. This complex is later broken down in
the small intestine by pancreatic proteases which enable vitamin B12 to bind to the glycoprotein IF, be
recognized (by cubilin) and absorbed by endocytosis in the enterocytes of the distal ileum. These steps
present a problem to older adults as 10%–30% have atrophic gastritis and therefore, reduced gastric
acid secretion which is essential to vitamin B12 release from food proteins [12]. The bioavailability of
vitamin B12 in any form or dose is estimated to be 40% in healthy adults with intact IF secretion [24].
Meat and meat products, milk and milk products and, fish and fish products were the top sources of
vitamin B12 in the Newcastle 85+ Study [30]. However, unlike some findings [44,45], but in agreement
with others [46], vitamin B12 intake from meat and meat products was not associated significantly
with plasma vitamin B12. Meat and meat products, especially liver (beef liver can reach to as much
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as 83 µg per 100 g [29]) and ruminant meat have very high concentrations of vitamin B12 and it is
reported that ileal receptors saturate with intakes of 1.5–2.5 µg of vitamin B12 per meal [47]. Only 50%
and 5% of vitamin B12 are absorbed with intakes of ~1 and 25 µg, respectively [24]. Others have found
that vitamin B12 from dairy products is very bioavailable [48] but also that vitamin B12 in yogurt and
cheese is not as bioavailable as that in milk in older individuals [46]. This could explain why vitamin
B12 intake from dairy products (that includes yogurt and cheese) was not associated with plasma B12
in this study.
4.4. MTHFR and RBC Folate, and FUT2 and Plasma Vitamin B12
Interestingly, and in contrast to most previous findings [49], participants heterozygous for the
A allele of the MTHFR gene had higher concentrations of RBC folate than those homozygous for
the G allele. This was not a reflection of higher folate or folic acid containing supplements intake.
Similar to previous findings [14,49,50], women with the FUT2 GG genotype had higher concentrations
of plasma vitamin B12. FUT2 encodes galactoside 2-alpha-L-fucosyltransferase 2 (EC: 2.4.1.69) which
is involved in the regulation of the H antigen and is a precursor of the ABO (H) antigens [50].
FUT2 variants (from the allele A) are proposed to be protective against Helicobacter pylori infection or
to increase IF production [14]. Both proposed explanations would explain the higher plasma vitamin
B12 concentrations in those homozygous for the G allele.
4.5. Strengths and Weaknesses
The Newcastle 85+ Study is a unique cohort owing to the age group, the large number of
participants and the extensive multidimensional health data. The study was socio-demographically
representative of the UK but the lack of ethnic diversity warrants caution when generalizing the
findings to a non-white population. The rapid processing of blood samples after venepuncture is
another strength of this study.
As dietary intake assessment consisted of a 24 h-MPR applied on two non-consecutive days,
the possibility of unusually high or low vitamin B12/folate intakes cannot be excluded. For practical
reasons, 24 h-MPRs were not conducted during the weekend, therefore food and drink eaten on
Fridays and Saturdays was not recalled. Although the MPR method involved several prompts to
avoid misreporting, misreporters have been estimated to be 26% of the cohort [28]. Even though
the food groups used in the analysis contributed to most of the folate and vitamin B12 intake, other
food sources might explain the remaining intake. Intakes of dietary folate equivalents (DFE) and of
the crystalline form of vitamin B12 could not be determined because supplement use was collected
qualitatively (type and brand but not frequency) and it was not certain which specific foods had been
fortified during the dietary collection period (2006/2007). A general limitation of most dietary surveys,
including ours, is that assessment of supplement usage may not be accurate by dietary intake records,
dietary recalls and other questionnaires [51]. Furthermore, the irregular use of supplements by survey
participants, including the alteration of usual patterns of supplement use during the period of dietary
data collection, further adds bias to the estimation of true supplement use [51]. It is worth mentioning
that the choice of vitamin B12 form used in supplements and fortified foods should also be taken into
consideration because of concerns associated with cyanide/thiocyanate from cyanocobalamin [52].
Holotranscobalamin measures the vitamin’s active form and because it might better reflect vitamin
B12 status than plasma vitamin B12, its use might have yielded different results. There is currently no
consensus on the biochemical threshold to use in order to define folate or vitamin B12 “inadequacy”,
especially in this population. Therefore, results from the binary logistic models might be different
if different thresholds were used. Furthermore, atrophic gastritis impairs folate and vitamin B12
absorption. If available, the incidence of atrophic gastritis or a proxy measure, such as Helicobacter
pylori infection, could have been used as an adjusting factor or to conduct a sensitivity analysis. The list
of SNPs used is not exhaustive and other polymorphisms, such as some SNPs in the TCN2 gene
(e.g., rs731991) may influence the folate and vitamin B12 intake–status relationship [53].
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5. Conclusions
In summary, almost one-fifth of the 85-year-old participants in the Newcastle 85+ Study had
deficient plasma vitamin B12 concentrations but only a few individuals had deficient folate status,
according to commonly used biochemical thresholds. Folate and vitamin B12 intakes were associated
to RBC folate and plasma B12, respectively and folate intake from cereals and cereal products was
strongly associated with RBC folate. This is possibly a consequence of voluntary folic acid fortification
of breakfast cereals in the UK, and makes this food group an important source of folate for this
population group. Estimates of the bioavailability of folate and vitamin B12 from total diets and
from commonly consumed food groups in the very old should be taken into account when setting
dietary guidelines.
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